{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:35:58Z","timestamp":1790375758803,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:00:00Z","timestamp":1641254400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s10620-021-07326-2","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T00:03:41Z","timestamp":1641254621000},"page":"4509-4517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Ethnicity Is an Important Consideration in Screening for Gastric Intestinal Metaplasia"],"prefix":"10.1007","volume":"67","author":[{"given":"Eugene","family":"Kligman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Szafron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Staggers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi C.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-4334","authenticated-orcid":false,"given":"Mohamed O.","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,4]]},"reference":[{"key":"7326_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"7326_CR2","first-page":"92","volume":"14","author":"DS Jencks","year":"2018","unstructured":"Jencks DS, Adam JD, Borum ML et al. Overview of current concepts in gastric intestinal metaplasia and gastric cancer. Gastroenterol Hepatol (NY) 2018;14:92\u2013101.","journal-title":"Gastroenterol Hepatol (NY)"},{"key":"7326_CR3","first-page":"26","volume":"14","author":"P Rawla","year":"2019","unstructured":"Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Prz Gastroenterol 2019;14:26\u201338.","journal-title":"Prz Gastroenterol"},{"key":"7326_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol 2020;18:534\u2013542.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7326_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","volume":"42","author":"P Correa","year":"2013","unstructured":"Correa P. Gastric cancer: overview. Gastroenterol Clin N Am 2013;42:211\u2013217.","journal-title":"Gastroenterol Clin N Am"},{"key":"7326_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.15430\/JCP.2015.20.1.25","volume":"20","author":"YH Park","year":"2015","unstructured":"Park YH, Kim N. Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer. J Cancer Prev 2015;20:25\u201340.","journal-title":"J Cancer Prev"},{"key":"7326_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.gastro.2008.01.071","volume":"134","author":"AC de Vries","year":"2008","unstructured":"de Vries AC, van Grieken NC, Looman CW et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008;134:945\u2013952.","journal-title":"Gastroenterology"},{"key":"7326_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ajg.2016.188","volume":"111","author":"D Li","year":"2016","unstructured":"Li D, Bautista MC, Jiang SF et al. Risks and predictors of gastric adenocarcinoma in patients with gastric intestinal metaplasia and dysplasia: a population-based study. Am J Gastroenterol 2016;111:1104\u20131113.","journal-title":"Am J Gastroenterol"},{"key":"7326_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ajg.2015.322","volume":"111","author":"NJ Shaheen","year":"2016","unstructured":"Shaheen NJ, Falk GW, Iyer PG et al. ACG clinical guideline: diagnosis and management of Barrett\u2019s esophagus. Am J Gastroenterol 2016;111:30\u201350.","journal-title":"Am J Gastroenterol"},{"key":"7326_CR10","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.gastro.2018.04.026","volume":"155","author":"X Zhang","year":"2018","unstructured":"Zhang X, Li M, Chen S et al. Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology 2018;155:347-354.e9.","journal-title":"Gastroenterology"},{"key":"7326_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1053\/j.gastro.2019.12.003","volume":"158","author":"S Gupta","year":"2020","unstructured":"Gupta S, Li D, El Serag HB et al. AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology 2020;158:693\u2013702.","journal-title":"Gastroenterology"},{"key":"7326_CR12","doi-asserted-by":"publisher","first-page":"e000563","DOI":"10.1136\/bmjgast-2020-000563","volume":"8","author":"PF Haastrup","year":"2021","unstructured":"Haastrup PF, Jarbol DE, Thompson W et al. When does proton pump inhibitor treatment become long term? A scoping review. BMJ Open Gastroenterol 2021;8:e000563.","journal-title":"BMJ Open Gastroenterol"},{"key":"7326_CR13","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1053\/j.gastro.2010.08.018","volume":"139","author":"A Sonnenberg","year":"2010","unstructured":"Sonnenberg A, Lash RH, Genta RM. A national study of Helicobactor pylori infection in gastric biopsy specimens. Gastroenterology 2010;139:1894-1901.e2.","journal-title":"Gastroenterology"},{"key":"7326_CR14","doi-asserted-by":"publisher","first-page":"856256","DOI":"10.1155\/2013\/856256","volume":"2013","author":"T Almouradi","year":"2013","unstructured":"Almouradi T, Hiatt T, Attar B. Gastric intestinal metaplasia in an underserved population in the USA: prevalence, epidemiologic and clinical features. Gastroenterol Res Pract 2013;2013:856256.","journal-title":"Gastroenterol Res Pract"},{"key":"7326_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.14309\/ajg.0000000000000498","volume":"115","author":"MC Tan","year":"2020","unstructured":"Tan MC, Mallepally N, Liu Y et al. Demographic and lifestyle risk factors for gastric intestinal metaplasia among US veterans. Am J Gastroenterol 2020;115:381\u2013387.","journal-title":"Am J Gastroenterol"},{"key":"7326_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.gie.2017.11.010","volume":"87","author":"AY Choi","year":"2018","unstructured":"Choi AY, Strate LL, Fix MC et al. Association of gastric intestinal metaplasia and East Asian ethnicity with the risk of gastric adenocarcinoma in a US population. Gastrointest Endosc 2018;87:1023\u20131028.","journal-title":"Gastrointest Endosc"},{"key":"7326_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1523-5378.2008.00604.x","volume":"13","author":"N Kim","year":"2008","unstructured":"Kim N, Park YS, Cho SI et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter 2008;13:245\u2013255.","journal-title":"Helicobacter"},{"key":"7326_CR18","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/MCG.0000000000000406","volume":"50","author":"TY Lee","year":"2016","unstructured":"Lee TY, Wang RC, Lee YC et al. The incidence of gastric adenocarcinoma among patients with gastric intestinal metaplasia: a long-term cohort study. J Clin Gastroenterol 2016;50:532\u2013537.","journal-title":"J Clin Gastroenterol"},{"key":"7326_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/S0016-5085(98)70422-6","volume":"114","author":"JQ Huang","year":"1998","unstructured":"Huang JQ, Sridhar S, Chen Y et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998;114:1169\u20131179.","journal-title":"Gastroenterology"},{"key":"7326_CR20","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1136\/gut.2003.034629","volume":"53","author":"WK Leung","year":"2004","unstructured":"Leung WK, Lin SR, Ching JY et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut 2004;53:1244\u20131249.","journal-title":"Gut"},{"key":"7326_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1053\/gast.2000.8550","volume":"119","author":"JJ Sung","year":"2000","unstructured":"Sung JJ, Lin SR, Ching JY et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000;119:7\u201314.","journal-title":"Gastroenterology"},{"key":"7326_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10120-015-0462-7","volume":"19","author":"HN Chen","year":"2016","unstructured":"Chen HN, Wang Z, Li X et al. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 2016;19:166\u2013175.","journal-title":"Gastric Cancer"},{"key":"7326_CR23","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/jnci\/84.16.1261","volume":"84","author":"RW Kneller","year":"1992","unstructured":"Kneller RW, You WC, Chang YS et al. Cigarette smoking and other risk factors for progression of precancerous stomach lesions. J Natl Cancer Inst 1992;84:1261\u20131266.","journal-title":"J Natl Cancer Inst"},{"key":"7326_CR24","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF01536915","volume":"35","author":"GN Stemmermann","year":"1990","unstructured":"Stemmermann GN, Nomura AM, Chyou PH et al. Impact of diet and smoking on risk of developing intestinal metaplasia of the stomach. Dig Dis Sci 1990;35:433\u2013438. https:\/\/doi.org\/10.1007\/BF01536915.","journal-title":"Dig Dis Sci"},{"key":"7326_CR25","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.dld.2014.08.034","volume":"46","author":"S Morais","year":"2014","unstructured":"Morais S, Rodrigues S, Amorim L et al. Tobacco smoking and intestinal metaplasia: systematic review and meta-analysis. Dig Liver Dis 2014;46:1031\u20131037.","journal-title":"Dig Liver Dis"},{"key":"7326_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/apt.14082","volume":"46","author":"R Pittayanon","year":"2017","unstructured":"Pittayanon R, Rerknimitr R, Klaikaew N et al. The risk of gastric cancer in patients with gastric intestinal metaplasia in 5-year follow-up. Aliment Pharmacol Ther 2017;46:40\u201345.","journal-title":"Aliment Pharmacol Ther"},{"key":"7326_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1053\/gast.1999.0029900319","volume":"117","author":"L Lundell","year":"1999","unstructured":"Lundell L, Miettinen P, Myrvold HE et al. Lack of effect of acid suppression therapy on gastric atrophy. Nordic Gerd Study Group. Gastroenterology 1999;117:319\u2013326.","journal-title":"Gastroenterology"},{"key":"7326_CR28","first-page":"CD010623","volume":"2014","author":"H Song","year":"2014","unstructured":"Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev 2014;2014:CD010623.","journal-title":"Cochrane Database Syst Rev"},{"key":"7326_CR29","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.gastro.2018.05.026","volume":"155","author":"M Saumoy","year":"2018","unstructured":"Saumoy M, Schneider Y, Shen N et al. Cost effectiveness of gastric cancer screening according to race and ethnicity. Gastroenterology 2018;155:648\u2013660.","journal-title":"Gastroenterology"},{"key":"7326_CR30","doi-asserted-by":"publisher","first-page":"402","DOI":"10.5009\/gnl17414","volume":"12","author":"SG Kim","year":"2018","unstructured":"Kim SG, Park CM, Lee NR et al. Long-term clinical outcomes of endoscopic submucosal dissection in patients with early gastric cancer: a prospective multicenter cohort study. Gut Liver 2018;12:402\u2013410.","journal-title":"Gut Liver"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07326-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T09:45:14Z","timestamp":1659606314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07326-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,4]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["7326"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07326-2","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,4]]},"assertion":[{"value":"24 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Mohamed Othman is a consultant for Boston Scientific Corporation, Olympus, ConMed and Apollo. He received research grants funding from Abbvie, Kangen pharmaceutical and Lucid Diagnostics. Kalpesh Patel is a consultant for Boston Scientific Corporation and ConMed. Other authors disclosed no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}